IPN, Delhi, India. Open 10-6pm

+91 9891296838 / 9811747774

etanercept Solution

etanercept Solution
for Subcutaneous Use Initial U.S. Approval: 1998

Facts about etanercept Solution

Approval Date: 2018
Proprietary Name: On Request
Active Ingredient(s): etanercept
Dosage Forms And Strengths:

  • 50 mg Single-use Prefilled Syringe
    0.98 mL of a 50 mg/mL solution of etanercept
  • 50 mg Single-use Prefilled SureClick® Autoinjector
    0.98 mL of a 50 mg/mL solution of etanercept
  • 25 mg Single-use Prefilled Syringe
    0.51 mL of a 50 mg/mL solution of etanercept
  • 25 mg Multiple-use Vial
    25 mg of etanercept

Company: Amgen
Diseases: rheumatoid arthritis, plaque psoriasis, psoriatic arthritis, ankylosing spondylitis and juvenile idiopathic arthritis
Medicine Approved By: –
European Medical Agency (EMA), Food and Drug Administration (FDA), Health Canada, Therapeutic Goods Administration (TGA), Medsafe (NZ)
Summary of FDA approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication.  Our professional will provide you with a step-by-step guide on how to legally and safely import “etanercept Solution” based on the information you provide.

Indian Pharma Network (IPN) Legitimate consultant and facilitator in the New Delhi, India. IPN has over two decades of industry experience and extensive coverage throughout India, including major cities such as Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, the North East, Pune, and other regions.

Contact Info

Basement-B-5-A, Ajit Singh House Building No.12, Yusuf Sarai, South Delhi,
New Delhi:110016 India.

M: +91 9811747774, 9891296838.
P / F: +91-11-26532129 / 26536398



Query For etanercept Solution

Approved accessible "etanercept Solution"

Etanercept is a tumor-necrosis factor (TNF) blocker, prescribed for ankylosing spondylitis (type of joint pain that affects your back), juvenile arthritis (arthritis-related condition that develops in children), psoriasis, and rheumatoid (inflammation of the joints) and psoriatic arthritis.

Enbrel is a medicine that contains the active substance etanercept. It is available as vials containing a powder that is made up into a solution for injection, and as prefilled syringes and pens containing a solution for injection.

How can 1 go about obtaining etanercept Solution?

If etanercept Solution are not yet approved or available in your area, you may request its price in India under a specific brand name through IPN. For assistance and guidance, you can contact us by providing complete details. Our pharmaceutical expert will help you find a suitable and practical solution to your query. To receive comprehensive support, please call us at +91 9891 296 838 (Mr. Tarun) / +91 9811 747 774 (Mr. Neeraj).

Enbrel (etanercept) Solution for Subcutaneous Use Initial U.S. Approval: 1998


Indian Pharma Network (IPN), New Delhi. India

Indian Pharma Network (IPN) is registered organisation in India, having highly qualified healthcare professionals of pharmaceutical Industry. Specialized in Oncology Products. Helped more than 6,000 patients. Registration Number : 07AAFFI2544E1ZO under GST Act.
Branch Offices in India : New Delhi | Bengaluru | Kolkata | Lucknow | Jaipur | Jodhpur.
Our Overseas Network UK | Russia | Brazil | Mexico | Germany | France| Italy | Spain | Japan | China| Australia | Brazil | Saudi Arabia | South Africa

Indian Pharma Network
60/4 1st Floor, T&T Building, Indian Oil Complex, Yusuf Sarai, Delhi 110016

Mobile / WhatsApp / Phone
M: +91 9811747774, 9891296838.
P: +91-11-26532129 / 26536398